-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Kestra Medical Techs, Raises Price Target to $28

Benzinga·12/12/2025 22:08:57
Listen to the news
Wells Fargo analyst Larry Biegelsen maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and raises the price target from $27 to $28.